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OBJECTIVES We sought to evaluate the plaque and patient variables related to arterial remodeling
responses of early, de novo atherosclerotic lesions involving the left coronary artery.
BACKGROUND Coronary artery remodeling is a lesion-specific process involving either enlargement or
shrinkage of atherosclerotic coronary arteries. There are little histologic data available
correlating plaque morphologic and patient clinical characteristics with the degree and type of
arterial remodeling in early atherosclerosis.
METHODS We studied 736 serial arterial sections from the left coronary system of 97 autopsy cases (mean
age 33 6 11 years) by correlating the arterial remodeling response to plaque with
demographic, serologic and histologic variables. Using the most proximal section as a
reference, and considering the expected degree of internal elastic lamina tapering, remodeling
was classified as positive (including neutral remodeling or compensatory enlargement) or
negative.
RESULTS Remodeling was classified as positive in 84.3% (compensatory in 30.6%) and negative in
15.7% of sections with an overall mean luminal stenosis of 10.4 6 9.9%. In the lesions with
the greatest arterial cross-sectional narrowing from each case, compensatory enlargement was
associated with higher high-density lipoprotein (HDL) cholesterol (59.4 6 27.2 mg/dl)
compared with either neutral (49.3 6 15.5 mg/dl) or negative remodeling (30.4 6 5.2 mg/dl;
p 5 0.019). In subjects with advanced atherosclerosis (maximum American Heart Association
histologic grade 5 atherosclerosis), there was a modest linear relationship between higher
HDL cholesterol and the propensity for positive remodeling (r2 5 0.37; p 5 0.025). On
multivariate analysis, only HDL cholesterol was related to the arterial remodeling response.
CONCLUSIONS Negative arterial remodeling occurs in early atherosclerosis. Higher HDL cholesterol may
favor positive remodeling. (J Am Coll Cardiol 1999;34:760–7) © 1999 by the American
College of Cardiology
Arterial remodeling in response to atherosclerotic plaque has
been described as an early adaptive process of arterial cross-
sectional area (CSA) enlargement that acts to “accommodate”
the enlarging plaque. The original description by Glagov et al.
(1) identified coronary arterial remodeling as compensatory
arterial enlargement. Their data demonstrated luminal dimen-
sions to be preserved via arterial expansion for a histologic
stenosis of up to 30% to 50%, with increases in plaque size
beyond this threshold resulting in a progressive loss of luminal
area. Thus, compensatory (“positive”) arterial remodeling acts
to limit the effect of the atherosclerotic plaque on luminal
narrowing. Others have subsequently confirmed compensatory
enlargement (2–10), although the magnitude of compensation
is controversial (11,12). More recent studies have extended
these early observations by describing so-called “paradoxical” or
“negative” arterial remodeling defined as the shrinkage of the
internal elastic lamina (IEL) in response to the enlarging
atherosclerotic plaque (7,12–14). These studies show that
negative remodeling is less common than positive remodeling.
The mechanism of arterial remodeling is uncertain be-
cause of the difficulty in longitudinally studying coronary
arteries over the lengthy time interval over which remodel-
ing likely occurs, and because of limited data from relevant
animal models (10). Postulated mechanisms include effects
of plaque size and shear stress (15–18) and the effects of
specific plaque characteristics including plaque eccentricity
(19,20) or fibrocalcific elements (13,14). Other proposed
mechanisms include the degradation of connective tissue
elements of the vessel wall by inflammatory mediators
(21,22) or effects mediated through a functionally deficient
vascular endothelium (15). In this study, we have investi-
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gated the relationships of the plaque and vessel wall inter-
action through a detailed examination of the morphology of
coronary arterial plaques. Specifically, we investigated the
relationships between plaque variables (such as plaque size
and morphologic characteristics), patient factors (including
those associated with endothelial dysfunction, such as to-
bacco use, hyperlipidemia and diabetes mellitus) and the
different arterial remodeling responses to atherosclerosis.
METHODS
We examined hearts from 97 subjects between the ages of
16 and 70 years who were consecutively referred to the
Armed Forces Institute of Pathology through an autopsy
consultation service provided to the Office of the Chief
Medical Examiner of the State of Maryland (Baltimore,
Maryland) between the years 1992 and 1994. Demographic
measures included age, gender, race, height, weight, cause
of death and heart weight (23). Body surface area (m2) was
calculated using the formula: (height [cm] 3 weight [kg])/
3,600)1/2 (24). Postmortem serologic measurements, as
previously described (23), included albumin, total and high-
density lipoprotien (HDL) cholesterol and thiocyanate
level. Red blood cells were analyzed for glycosylated hemo-
globin as a marker for diabetes mellitus (25). All cases were
screened for postmortem serum quality using serum albu-
min (26). Cases with a serum albumin below 2.5mg/dl (the
lower limit of normal for the reference laboratory) were
considered to have degradation of serum and were therefore
excluded from this study. Serum thiocyanate indicated
tobacco use when the serum level was $90 mol/L (23).
The hearts were weighed and perfusion fixed via the
aortic stump at 100 mm Hg with 10% buffered formalde-
hyde for 30 min to distend the coronary arteries to physi-
ologic pressure. Sections for histology were cut perpendic-
ular to the long axis of the artery from serial locations
approximately every 10 mm in the left anterior descending
(LAD; five sections per artery) and left circumflex (LCX;
three sections per artery) coronary arteries. Tissues were
dehydrated in a graded series of alcohols and embedded in
paraffin. Sections were cut (4 to 5 mm thick) and stained
with hematoxylin and eosin and Movat pentachrome.
Morphometry was performed by computerized planimetry
(version 2.5; IP Lab Spectrum, Vienna, VA). Movat
pentachrome-stained arterial sections were magnified and dig-
itized, and the luminal, IEL and external elastic lamina (EEL)
perimeters were measured. Sections (n 5 25) taken at a side
branch location or that were considered to be distorted from
processing artifact were excluded, thus leaving 736 sections for
further analysis. Arterial areas were calculated from the diam-
eter values derived from the measured arterial perimeter
(area 5 pr2) to avoid artifacts encountered from distortion of
arterial shape during processing. Plaque was defined as the area
enclosed between the IEL and the lumen. Plaque area was
calculated as the difference between IEL and luminal area
measurements. Percentage luminal stenosis was calculated as
the plaque area/IEL area 3 100 (1). This calculation repre-
sents the pathologically defined luminal stenosis, and may not
reflect an actual decrease in lumen area (e.g., as defined on
coronary angiography).
Histologic sections were graded on light microscopy
according to the classification scheme of the Committee on
Vascular Lesions of the Council on Arteriosclerosis, Amer-
ican Heart Association (AHA grade) (27,28). Lesions were
further histologically characterized according to their asso-
ciated degree of eccentricity. Concentric plaques were those
plaques with a plaque thickness greater than medial thick-
ness along the entire circumference of the vessel. Otherwise,
the plaque was classified as eccentric. The degree of eccen-
tricity was defined as the percentage of the IEL circumfer-
ence occupied by the eccentric plaque. Inflammatory cells
were identified as present or absent, and graded as follows:
0 (absent), 1 (minimal inflammatory cells), 2 (single collec-
tion of inflammatory cells in a discrete location), 3 (multiple
foci of inflammatory cell infiltrates) and 4 (extensive inflam-
matory cell infiltrates throughout the arterial wall). Calcium
was graded as present or absent, and semiquantitated on a
scale of 0 to 4 according to the number of quadrants
containing calcium on the arterial cross section. For com-
parison of cases, histologic characteristics were considered as
present in any section, or absent.
Classification of arterial remodeling. Arterial sections
were classified as demonstrating either positive or negative
remodeling (Fig. 1). For each artery (LAD and LCX), the
most proximal section was used as the initial reference for
arterial size. The mean percent area stenosis in these reference
sections was 11.2 6 8.0%. For classification of the type of
remodeling present in the more distal sections, the IEL area of
each section was compared with the IEL area of the reference
section and to the expected amount of “normal” arterial
tapering. Arterial tapering was determined by measurement of
IEL areas in a subset of 10 cases selected on the basis of having
only minimal intimal thickening (total intimal CSA ,1 mm2).
The normal vessel tapering between serial sections (approxi-
mately 10 mm between sections) was 1.20 6 2.40 mm2/cm
for the LAD and 1.20 6 2.15 mm2/cm for the LCX.
Abnormal tapering between adjacent sections was defined as
tapering greater than the mean 1 2 SD of the expected
tapering. Based upon IEL areas in this study, abnormal
tapering was present when a 25% or greater decrease in IEL
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area was present between sections. This is comparable with
data on arterial tapering determined by intravascular ultra-
sound, as reported by Mintz et al. (14,29).
Positive remodeling was defined as an increase in IEL
area in successive sections (compensatory enlargement), or
vessel tapering within the expected range defined as normal
(neutral remodeling). Negative remodeling was identified as
a decrement in IEL area, relative to the adjacent proximal
sections, that was greater than the anticipated change with
normal vessel tapering (Fig. 1). Two separate methods were
used to classify the overall remodeling characteristics of
individual cases. In the first method, cases were classified as
overall demonstrating positive or negative remodeling. A
case with all sections demonstrating positive remodeling
was considered to have overall positive remodeling (n 5 42),
whereas a case with any single section demonstrating
negative remodeling was classified as a “negative remodeler”
(n 5 55). In the second method, a mean remodeling score
was calculated for each case by averaging assigned values of
either 1 (positive remodeling), 2 (neutral remodeling) or 3
(negative remodeling) from each section.
Statistical analysis. The arterial remodeling response to
atherosclerotic plaque was correlated with the serologic and
histologic variables using the patient as the unit of analysis.
Continuous variables were tested using a t test for the means
of independent samples. Categorical variables were tested with
a chi-square test or factorial analysis of variance (ANOVA).
Univariate analyses were used to identify patient or histologic
predictors of the arterial remodeling response. Multivariate
linear regression analysis was used to explore the relationship
between the arterial remodeling response and the variables
HDL cholesterol and plaque area. For all statistical tests, a
two-tailed p value of #0.05 was considered significant.
RESULTS
Study cases. The characteristics of the 97 study cases are
displayed in Table 1. Mean age was 33.0 6 11.2 years.
Table 1. Characteristics of Study Cases
Characteristic Mean 6 SD Range
Number 97
Age, yrs 33 6 11 16–74
Race 55 Black, 42 White
Heart weight, g 415 6 71 247–690
Body surface area, m2 2.0 6 0.2 1.5–2.7
Total cholesterol, mg/dL 209 6 61 93–372
HDL cholesterol, mg/dL 53 6 22 22–138
Glycosylated hemoglobin, % 6.2 6 1.7 2.9–20.2
Tobacco use, n, % 47 (48.5)
Plaque size, mm2 1.7 6 1.9 0.0–11.39
IEL area, mm2 14.6 6 6.3 1.3–41.0
Luminal stenosis, % 10.4 6 9.9 0.0–58.0
Figure 1. Schematic representation of the methods used to classify different types of arterial remodeling. Definitions as described in
“Methods.”
762 Taylor et al. JACC Vol. 34, No. 3, 1999
HDL and Arterial Remodeling September 1999:760–7
Serum thiocyanate levels indicated recent tobacco use in 47
cases. From the original group of 736 evaluated arterial
sections, the most proximal section of both the LAD and
LCX (194 sections) was used as a size reference. In the
remaining 542 arterial sections, the mean IEL CSA was
14.6 6 6.3 mm2, and the mean plaque CSA was 1.7 6
1.9 mm2. Histologic characteristics of the study group
included lesion eccentricity in 162 sections (29.9%), calcium
in 69 (12.7%; grade 1, 6.5%; grade 2, 3.7%; grade 3, 2.6%;
grade 4, 0%) and inflammation in 116 (21.4%; grade 1,
14.9%; grade 2, 4.6%; grade 3, 1.8%; grade 4, 0%).
Remodeling was classified in the 542 arterial segments as
positive in 457 (84.3%) and negative in 85 (15.7%) sections.
Sections with plaque area $1 mm2 had larger IEL areas
than sections with plaque area ,1 mm2 (Fig. 2). The mean
IEL, plaque (Fig. 3), and luminal CSA were significantly
larger in sections with positive versus those with negative
remodeling. Negative remodeling was more common
(22.2%) and compensatory enlargement was less common
(16.5%) in sections with minimal plaque (,1 mm2) than in
sections with larger plaque area (.1 mm2) (negative remod-
eling 9.6%, compensatory enlargement 43.8%; p , 0.0001).
Classification of the remodeling characteristics of each
case included “positive” remodeling in 42 cases, and negative
remodeling (based on the presence of at least one section
with negative remodeling) in 55 cases. The univariate
comparisons of demographic, serologic and histologic vari-
ables for the cases classified as positive and negative remod-
eling are shown in Table 2. Total serum cholesterol was
significantly higher in cases classified as “positive” remod-
eling.
Remodeling and HDL cholesterol. The single lesions
from each case with the greatest CSA narrowing (percent
luminal stenosis) were evaluated to investigate the relation-
ship between cholesterol and remodeling. Cases were in-
cluded in this analysis when the lesion with the greatest
percent luminal stenosis was not the most proximal refer-
ence segment. In this analysis, HDL cholesterol was signif-
icantly higher for cases with compensatory enlargement
(59.4 6 27.2 mg/dl) versus those sections demonstrating
neutral (49.3 6 15.5 mg/dl) or negative remodeling (30.4 6
5.2 mg/dl) (ANOVA p 5 0.019) (Fig. 4). Total cholesterol
tended to be higher in the groups with compensatory and
neutral remodeling, although these differences were not
significant. The ratio of total and HDL cholesterol tended
to be increased in the group with negative remodeling
(6.3 6 2.7) compared with either compensatory (4.5 6 2.1;
p 5 0.08) or neutral remodeling (4.5 6 1.8; p 5 0.07).
There were no significant univariate relationships between
the remodeling characteristics of these lesions and all
histologic variables, including plaque calcification, inflam-
mation, eccentricity or atherosclerosis grade. The frequency
of smoking did not differ (p 5 0.38) among lesions with
compensatory (8/20, 40%), neutral (15/26, 58%) or negative
(2/5, 40%) remodeling. Multivariate analysis including the
variables HDL cholesterol and plaque area showed a sig-
nificant relationship between HDL cholesterol and positive
remodeling (p 5 0.006).
To confirm these results in the most severe lesions on a
percent luminal stenosis basis, further subgroup analysis was
performed on cases having at least one section with ad-
vanced atherosclerosis (AHA grade 5; n 5 13 cases; n 5 72
sections) to analyze the associations of demographic and
serologic variables with arterial remodeling. In this analysis,
the mean HDL cholesterol level was significantly higher for
cases with positive remodeling (68.4 6 27.9 mg/dl) versus
those with negative remodeling (35.9 6 14.9 mg/dl; p 5
0.018). There was a significant linear relationship between
HDL cholesterol and the calculated average remodeling
score for these cases. Higher HDL cholesterol was associ-
ated with an overall propensity for positive remodeling (r2 5
0.37; p 5 0.025) (Fig. 5).
DISCUSSION
Recent studies on arterial remodeling in atherosclerosis have
indicated that arterial remodeling is a heterogeneous process
including both positive and negative remodeling (7,13,14).
The clinical importance of these divergent arterial responses
to atherosclerotic plaque is readily apparent. Whereas arte-
rial enlargement may delay the onset of obstructive conse-
Figure 2. Mean IEL area (mm2) for sections with plaque area
,1 mm2 (open bars) and $1 mm2 (black bars) for serial LAD
sections, proximal to distal (ANOVA p , 0.0001). At all sites,
IEL area was smaller in sections with minimal plaque.
Figure 3. Mean plaque area (mm2) for sections with compensa-
tory, neutral and negative remodeling (ANOVA p , 0.0001)
(mean 6 standard error).
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quences of atherosclerosis, arterial narrowing may accelerate
the development of symptomatic atherosclerosis by contrib-
uting to the luminal reduction created by the plaque (7,14).
An important example of the impact of negative remodeling
is found in postangioplasty restenosis where a significant
proportion of the late loss in luminal area may occur because
of vessel shrinkage rather than plaque growth (30,31). Thus,
the interaction between an atherosclerotic plaque and the
arterial wall, and the factors, particularly modifiable coro-
nary risk factors, that may modulate this process have
important consequences for patients with atherosclerosis.
Mechanisms of arterial remodeling. Several hypotheses
on the mechanism of arterial remodeling have been pro-
posed. One hypothesis relates arterial remodeling to plaque
size, with arterial enlargement resulting from flow-mediated
changes in shear stress created by the enlarging atheroscle-
rotic plaque (9,16–18). This hypothesis arose from early
observations on compensatory arterial enlargement and
provided the initial evidence relating arterial size to the size
of the underlying plaque (1,2). However, these data, derived
from pooled analysis of study subjects, have subsequently
been questioned because normal interpatient differences in
arterial size might heavily influence this relationship (11).
These data also provide no insights into the mechanism of
negative remodeling that has been associated with smaller
arterial plaques (14). Recent data provide a potential expla-
nation for this seeming paradox, as negative remodeling has
been associated with the presence of fibrocalcific atheroscle-
rotic elements (13,14) that may impair the capacity of an
arterial segment to enlarge.
Other hypotheses on the mechanism of arterial remod-
eling have been proposed. A functionally intact endothelial
surface may modulate arterial remodeling (15). This hy-
pothesis has been indirectly derived through associations of
negative remodeling in de novo and restenotic lesions with
coronary risk factors that impair vascular endothelial cell
function, including tobacco use (13), hyperlipidemia (13)
and diabetes mellitus (31). The endothelium can theoreti-
Figure 4. Mean HDL cholesterol values associated with different
types of arterial remodeling including compensatory (open bar),
neutral (hatched bar) and negative (black bar) subtypes (ANOVA
p 5 0.019) (mean 6 standard deviation).
Figure 5. Relationship between the remodeling score and HDL
cholesterol for cases with advanced (AHA grade 5) atherosclerosis.
A higher remodeling score indicates a greater frequency of sections
displaying negative remodeling (r2 5 0.37; p 5 0.025).




Cases n 5 42 n 5 55
Age 32.3 6 9.4 34.2 6 12.1 0.39
Body surface area, m2 1.97 6 0.27 1.97 6 0.21 0.94
Heart weight, g 391 6 66 400 6 87 0.58
Tobacco use, n, % 20 (47.6) 27 (49.1) 0.89
Glycosylated hemoglobin, % 6.3 6 0.9 6.1 6 2.1 0.66
Total cholesterol, mg/dL 223.9 6 64.3 196.7 6 56.6 0.03
HDL cholesterol, mg/dL 55.3 6 21.1 52.1 6 22.9 0.50
Mean plaque area (mm2/section) 1.54 6 1.24 1.59 6 1.08 0.83
Plaque calcification, n, % 11 (35.5) 19 (34.5) 0.38
Plaque inflammation, n, % 18 (42.9) 26 (47.3) 0.67
Plaque eccentricity, n, % 17 (40.5) 16 (29.1) 0.21
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cally sense changes in shear stress or humoral factors,
transduce these signals to adjacent cells and release sub-
stances that may participate in the remodeling process (15).
Within this paradigm, an endothelial lining that is physi-
cally or functionally deficient could impair the production of
locally acting vasodilating substances, such as nitric oxide,
and impede arterial remodeling. Lastly, inflammatory me-
diators, such as matrix metalloproteinases derived from
macrophages contained within the atherosclerotic plaque
(32), may degrade fibrous elements in the vessel wall leading
to vessel enlargement (21,22).
Each of these hypotheses on the mechanism of arterial
remodeling has been primarily derived from advanced ath-
erosclerosis, with many of the most recent observations on
arterial remodeling made in symptomatic patients undergo-
ing coronary revascularization. Thus, these data may be
biased for features seen predominantly in advanced ather-
oma, such as calcification, and be less applicable to the
broader range of atherosclerotic lesions.
The Present Study
Our data, from de novo and predominantly early atheroscle-
rosis, provide further insights into the associations and possible
mechanisms of arterial remodeling.
The role of HDL in remodeling. We found a significant
relationship between higher HDL cholesterol and positive
remodeling in advanced atherosclerosis. Low HDL choles-
terol is an established risk factor for the development of
coronary artery disease, whereas medications that increase
HDL cholesterol reduce myocardial ischemia and the need
for coronary revascularization (33–35). Our data suggest
that HDL-mediated arterial wall remodeling, in addition to
remodeling of the atherosclerotic plaque by reverse choles-
terol transport (36), may account for the results of athero-
sclerotic regression trials. Ongoing studies using intravas-
cular ultrasound for the evaluation of atherosclerotic
regression should provide further insights into this issue.
Negative remodeling and previous studies. This is the
first study to demonstrate that negative remodeling, previ-
ously described in advanced, symptomatic atherosclerosis,
occurs in early atherosclerosis. Two factors previously asso-
ciated with negative remodeling are tobacco exposure and
arterial calcification. Fibrocalcific plaque elements and su-
perficial calcium, as defined by intravascular ultrasound,
have been associated with negative arterial remodeling (14).
This possible relationship has conceptual appeal, consider-
ing that a noncompliant, calcified arterial wall may be
incapable of enlarging to accommodate an enlarging plaque
due to specific biomechanical characteristics (37). However,
the high frequency and diffuse nature of calcified elements
in advanced atherosclerosis undergoing revascularization
(38,39) raise the question of the importance of the associ-
ation between negative remodeling and fibrocalcific plaques.
In our study of predominantly early atherosclerosis, calcified
elements were less prevalent than these studies, yet the
prevalence of negative remodeling was similar. We found
that calcification was not an independent predictor of
arterial remodeling, an observation that is consistent with
the findings of others (10). Also, in contrast to a previous
study (13), we found that tobacco use was unrelated to
negative arterial remodeling. Given these contradictory data
from different patient populations, the associations of vas-
cular calcification and tobacco use with negative arterial
remodeling remain speculative.
Study limitations. Autopsy studies are limited by pertur-
bation of the tissue at the time of pathologic examination,
and vessel distortion from fixation and sectioning. However,
our methods including pressure fixation of the coronary
arteries via the aortic stump and geometric correction of the
IEL area based on the measured IEL perimeter should
minimize the effect of processing artifacts. Intravascular
ultrasound has the advantage of identifying the least dis-
eased proximal arterial segment before side branches for
determination of an appropriate reference site. Intervening
arterial side branches possibly affect the measurement of
arterial areas, but this has been included in calculations of
normal vessel tapering. Despite the potential effect of these
side branches, the anticipated amount of arterial tapering
was comparable with that defined by Mintz et al. with
intravascular ultrasound (29). Conversely, direct measure-
ment of arterial areas via pathologic morphometry avoids
errors arising in approximating the arterial borders in
fibrocalcific plaques during ultrasound measurements (40).
Autopsy tissues provide an important means of evaluating
a large number of arterial segments in comparison with a
reference segment, but do not allow for the serial evaluation
of plaque morphology across time. The ubiquitous presence
of atherosclerosis, even in patients with angiographically
normal coronary vessels, creates uncertainty in the definition
of a particular segment as a size reference (41). Thus, in our
study, as in any study of arterial remodeling, the reference
segments may have undergone positive or negative remod-
eling and created error in the categorization of remodeling
in the distal segments. Despite this concern, the IEL CSA
was greatest in sections demonstrating positive remodeling,
and least in sections demonstrating negative remodeling, as
anticipated based on the current paradigm of arterial re-
modeling. An effect of reference segment atherosclerosis is
likely minor in the present study because of the minimal
CSA narrowing present in the proximal reference segments
compared with previous studies with reference segments
that have contained up to 30% to 50% CSA narrowing
(7,14). Our data on HDL cholesterol and remodeling are
derived from selected subgroups of patients, and thus should
be cautiously interpreted and require replication in future
studies. Lastly, differences in exposure duration could ac-
count for the absence of a relationship between tobacco use
(13) and negative remodeling in our study.
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CONCLUSIONS
Arterial remodeling occurs in both early and in advanced
atherosclerosis. Negative arterial remodeling occurs even with
small accumulations of atherosclerotic plaque. In more severe
atherosclerosis, higher HDL cholesterol may favor positive
remodeling and thereby contribute to the beneficial clinical
effects of cholesterol-modifying pharmacologic agents.
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